JournalTOCs

Journal of Enzyme Inhibition and Medicinal Chemistry
Journal Prestige (SJR): 1.04

Citation Impact (citeScore): 3
Number of Followers: 4

This is an Open Access Journal

Open Access journal
ISSN (Print) 1475-6366 - ISSN (Online) 1475-6374
Published by Taylor and Francis

[2600 journals]

Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease
inhibitors
- Volume 36, Issue 1, December 2021, Page 147-153
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-12T09:54:45Z
  DOI: 10.1080/14756366.2020.1850710
  Issue No: Vol. 36, No. 1 (2021)
Preclinical in vitro screening of newly synthesised amidino substituted
benzimidazoles and benzothiazoles
- Volume 36, Issue 1, December 2021, Page 163-174
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-06T01:49:19Z
  DOI: 10.1080/14756366.2020.1850711
  Issue No: Vol. 36, No. 1 (2021)
Nanovesicles released by OKT3 hybridoma express fully active antibodies
- Volume 36, Issue 1, December 2021, Page 175-182
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-06T01:50:34Z
  DOI: 10.1080/14756366.2020.1852401
  Issue No: Vol. 36, No. 1 (2021)
The insulin-degrading enzyme as a link between insulin and neuropeptides
metabolism
- Volume 36, Issue 1, December 2021, Page 183-187
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-06T03:09:31Z
  DOI: 10.1080/14756366.2020.1850712
  Issue No: Vol. 36, No. 1 (2021)
Morpholine-based chalcones as dual-acting monoamine oxidase-B and
- Volume 36, Issue 1, December 2021, Page 188-197
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-12T09:50:57Z
  DOI: 10.1080/14756366.2020.1842390
  Issue No: Vol. 36, No. 1 (2021)
Design, synthesis and evaluation of carbazole derivatives as potential
antimicrobial agents
- Volume 36, Issue 1, December 2021, Page 295-306
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-06T01:58:47Z
  DOI: 10.1080/14756366.2020.1850713
  Issue No: Vol. 36, No. 1 (2021)
Anticancer active trifluoromethylated fused triazinones are safe for
early-life stages of zebrafish (Danio rerio) and reveal a proapoptotic
action
- Volume 36, Issue 1, December 2021, Page 336-344
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-04T09:39:17Z
  DOI: 10.1080/14756366.2020.1865944
  Issue No: Vol. 36, No. 1 (2021)
Anion inhibition studies of the Zn(II)-bound ι-carbonic anhydrase from
the Gram-negative bacterium Burkholderia territorii
- Volume 36, Issue 1, December 2021, Page 372-376
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-04T09:39:45Z
  DOI: 10.1080/14756366.2020.1867122
  Issue No: Vol. 36, No. 1 (2021)
Development of novel isatin–nicotinohydrazide hybrids with potent
activity against susceptible/resistant Mycobacterium tuberculosis and
bronchitis causing–bacteria
- Volume 36, Issue 1, December 2021, Page 384-393
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-07T08:17:24Z
  DOI: 10.1080/14756366.2020.1868450
  Issue No: Vol. 36, No. 1 (2021)
Evaluating the efficiency of enzyme accelerated CO2 capture: chemical
kinetics modelling for interpreting measurement results
- Volume 36, Issue 1, December 2021, Page 394-401
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-12T08:15:25Z
  DOI: 10.1080/14756366.2020.1864631
  Issue No: Vol. 36, No. 1 (2021)
Development and characterisation of SMURF2-targeting modifiers
- Volume 36, Issue 1, December 2021, Page 401-409
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-12T09:57:43Z
  DOI: 10.1080/14756366.2020.1871337
  Issue No: Vol. 36, No. 1 (2021)
Design, synthesis, and in vitro evaluation of BP-1-102 analogs with
modified hydrophobic fragments for STAT3 inhibition
- Volume 36, Issue 1, December 2021, Page 410-424
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-14T05:27:04Z
  DOI: 10.1080/14756366.2020.1871336
  Issue No: Vol. 36, No. 1 (2021)
Discovery of indole-3-butyric acid derivatives as potent histone
deacetylase inhibitors
- Volume 36, Issue 1, December 2021, Page 425-436
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-15T04:33:46Z
  DOI: 10.1080/14756366.2020.1870457
  Issue No: Vol. 36, No. 1 (2021)
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are
simultaneous reactivators of acetylcholinesterase and
butyrylcholinesterase inhibited by nerve agent surrogates
- Volume 36, Issue 1, December 2021, Page 437-449
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-20T05:47:21Z
  DOI: 10.1080/14756366.2020.1869954
  Issue No: Vol. 36, No. 1 (2021)
Thiophen urea derivatives as a new class of hepatitis C virus entry
inhibitors
- Volume 36, Issue 1, December 2021, Page 462-468
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-18T05:16:16Z
  DOI: 10.1080/14756366.2020.1870456
  Issue No: Vol. 36, No. 1 (2021)
Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic
bacterium Vibrio cholerae with aromatic sulphonamides and clinically
licenced drugs – a joint docking/molecular dynamics study
- Volume 36, Issue 1, December 2021, Page 469-479
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-21T04:29:58Z
  DOI: 10.1080/14756366.2020.1862102
  Issue No: Vol. 36, No. 1 (2021)
Discovery of new acetylcholinesterase inhibitors for Alzheimer’s
disease: virtual screening and in vitro characterisation
- Volume 36, Issue 1, December 2021, Page 491-496
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2021-01-22T05:38:28Z
  DOI: 10.1080/14756366.2021.1876685
  Issue No: Vol. 36, No. 1 (2021)
HT-SuMD: making molecular dynamics simulations suitable for fragment-based
screening. A comparative study with NMR
- Volume 36, Issue 1, December 2021, Page 1-14
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-29T04:39:58Z
  DOI: 10.1080/14756366.2020.1838499
  Issue No: Vol. 36, No. 1 (2020)
Pharmacophore-based virtual screening, synthesis, biological evaluation,
and molecular docking study of novel pyrrolizines bearing urea/thiourea
moieties with potential cytotoxicity and CDK inhibitory activities
- Volume 36, Issue 1, December 2021, Page 15-33
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-26T09:02:42Z
  DOI: 10.1080/14756366.2020.1837124
  Issue No: Vol. 36, No. 1 (2020)
Identification of histone deacetylase inhibitors with (arylidene)aminoxy
scaffold active in uveal melanoma cell lines
- Volume 36, Issue 1, December 2021, Page 34-47
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-26T09:00:39Z
  DOI: 10.1080/14756366.2020.1835883
  Issue No: Vol. 36, No. 1 (2020)
Activation of carbonic anhydrases from human brain by amino alcohol oxime
ethers: towards human carbonic anhydrase VII selective activators
- Volume 36, Issue 1, December 2021, Page 48-57
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-26T06:47:51Z
  DOI: 10.1080/14756366.2020.1838501
  Issue No: Vol. 36, No. 1 (2020)
Synthesis and evaluation of anticancer activities of 2- or 4-substituted
3-(N-benzyltriazolylmethyl)-13α-oestrone derivatives
- Volume 36, Issue 1, December 2021, Page 58-67
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-30T06:01:19Z
  DOI: 10.1080/14756366.2020.1838500
  Issue No: Vol. 36, No. 1 (2020)
Lipoprotein-associated phospholipase A2 (Lp-PLA2) – possible diagnostic
and risk biomarker in chronic ischaemic heart disease
- Volume 36, Issue 1, December 2021, Page 68-73
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-11-14T06:56:30Z
  DOI: 10.1080/14756366.2020.1839447
  Issue No: Vol. 36, No. 1 (2020)
Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of
histone deacetylase isoforms
- Volume 36, Issue 1, December 2021, Page 74-84
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-11-09T05:48:57Z
  DOI: 10.1080/14756366.2020.1839446
  Issue No: Vol. 36, No. 1 (2020)
The SNAP-tag technology revised: an effective chemo-enzymatic approach by
using a universal azide-based substrate
- Volume 36, Issue 1, December 2021, Page 85-97
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-10-30T06:07:23Z
  DOI: 10.1080/14756366.2020.1841182
  Issue No: Vol. 36, No. 1 (2020)
Identification of a dual TAOK1 and MAP4K5 inhibitor using a
structure-based virtual screening approach
- Volume 36, Issue 1, December 2021, Page 98-108
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-11-10T05:08:28Z
  DOI: 10.1080/14756366.2020.1843452
  Issue No: Vol. 36, No. 1 (2020)
Inhibitory evaluation of Curculigo latifolia on α-glucosidase, DPP (IV)
and in vitro studies in antidiabetic with molecular docking relevance to
type 2 diabetes mellitus
- Volume 36, Issue 1, December 2021, Page 109-121
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-11-30T04:37:35Z
  DOI: 10.1080/14756366.2020.1844680
  Issue No: Vol. 36, No. 1 (2020)
Differences in the efficiency of 3-deazathiamine and oxythiamine
pyrophosphates as inhibitors of pyruvate dehydrogenase complex and growth
of HeLa cells in vitro
- Volume 36, Issue 1, December 2021, Page 122-129
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-11-14T06:53:33Z
  DOI: 10.1080/14756366.2020.1844681
  Issue No: Vol. 36, No. 1 (2020)
Analogues of 2′-hydroxychalcone with modified C4-substituents as the
inhibitors against human acetylcholinesterase
- Volume 36, Issue 1, December 2021, Page 130-137
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-11-27T03:44:43Z
  DOI: 10.1080/14756366.2020.1847100
  Issue No: Vol. 36, No. 1 (2020)
Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin
derivatives as strong BuChE inhibitors
- Volume 36, Issue 1, December 2021, Page 138-146
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-11-24T05:01:10Z
  DOI: 10.1080/14756366.2020.1847101
  Issue No: Vol. 36, No. 1 (2020)
Dammarane triterpenes targeting α-synuclein: biological activity and
evaluation of binding sites by molecular docking
- Volume 36, Issue 1, December 2021, Page 154-162
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-14T08:29:01Z
  DOI: 10.1080/14756366.2020.1851216
  Issue No: Vol. 36, No. 1 (2020)
Discovery of orally active chalcones as histone lysine specific
demethylase 1 inhibitors for the treatment of leukaemia
- Volume 36, Issue 1, December 2021, Page 207-217
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-14T07:35:14Z
  DOI: 10.1080/14756366.2020.1852556
  Issue No: Vol. 36, No. 1 (2020)
Synthesis of some quinazolinones inspired from the natural alkaloid
L-norephedrine as EGFR inhibitors and radiosensitizers
- Volume 36, Issue 1, December 2021, Page 218-237
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-28T08:30:13Z
  DOI: 10.1080/14756366.2020.1854243
  Issue No: Vol. 36, No. 1 (2020)
New potent steroid sulphatase inhibitors based on
6-(1-phenyl-1H-1,2,3-triazol-4-yl)naphthalen-2-yl sulphamate derivatives
- Volume 36, Issue 1, December 2021, Page 238-247
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-16T07:47:52Z
  DOI: 10.1080/14756366.2020.1858820
  Issue No: Vol. 36, No. 1 (2020)
Production, purification and biochemical characterisation of a novel
lipase from a newly identified lipolytic bacterium Staphylococcus caprae
NCU S6
- Volume 36, Issue 1, December 2021, Page 248-256
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-17T08:37:47Z
  DOI: 10.1080/14756366.2020.1861607
  Issue No: Vol. 36, No. 1 (2020)
Screening the dermatological potential of plectranthus species components:
antioxidant and inhibitory capacities over elastase, collagenase and
tyrosinase
- Volume 36, Issue 1, December 2021, Page 257-269
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-16T07:59:18Z
  DOI: 10.1080/14756366.2020.1862099
  Issue No: Vol. 36, No. 1 (2020)
Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β
inhibitors targeting breast cancer: design, synthesis, biological
evaluation, and in silico studies
- Volume 36, Issue 1, December 2021, Page 270-285
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-17T04:45:07Z
  DOI: 10.1080/14756366.2020.1862101
  Issue No: Vol. 36, No. 1 (2020)
Novel positive allosteric modulators of A2B adenosine receptor acting as
bone mineralisation promoters
- Volume 36, Issue 1, December 2021, Page 286-294
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-18T04:40:18Z
  DOI: 10.1080/14756366.2020.1862103
  Issue No: Vol. 36, No. 1 (2020)
Novel piperazine–chalcone hybrids and related pyrazoline analogues
targeting VEGFR-2 kinase; design, synthesis, molecular docking studies,
and anticancer evaluation
- Volume 36, Issue 1, December 2021, Page 307-318
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-22T06:26:37Z
  DOI: 10.1080/14756366.2020.1861606
  Issue No: Vol. 36, No. 1 (2020)
Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as
novel apoptotic and anti-proliferative agents towards colorectal cancer
cells
- Volume 36, Issue 1, December 2021, Page 319-328
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-21T06:02:01Z
  DOI: 10.1080/14756366.2020.1862100
  Issue No: Vol. 36, No. 1 (2020)
Inhibition of the β-carbonic anhydrase from the protozoan pathogen
Trichomonas vaginalis with sulphonamides
- Volume 36, Issue 1, December 2021, Page 329-334
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-28T08:29:41Z
  DOI: 10.1080/14756366.2020.1863958
  Issue No: Vol. 36, No. 1 (2020)
Synthesis, telomerase inhibitory and anticancer activity of new
2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
- Volume 36, Issue 1, December 2021, Page 344-360
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-28T05:09:38Z
  DOI: 10.1080/14756366.2020.1864630
  Issue No: Vol. 36, No. 1 (2020)
Thioredoxin-dependent system. Application of inhibitors
- Volume 36, Issue 1, December 2021, Page 362-371
  .
  Journal of Enzyme Inhibition and Medicinal Chemistry2020-12-28T05:19:35Z
  DOI: 10.1080/14756366.2020.1867121
  Issue No: Vol. 36, No. 1 (2020)